Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims
By Grabar Law |
Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...
Read More 
Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims
By Grabar Law |
Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...
Read More 
Grabar Law Office Files Federal Lawsuit Against Major Insulin Manufacturers and PBMs on Behalf of the University of Pennsylvania
By Grabar Law |
Grabar Law Office has filed a complaint on behalf of The Trustees of the University of Pennsylvania in the United ...
Read More 
Grabar Law Office In the News: Geron Shareholder Sues Execs Over Drug Launch Claims
By Grabar Law |
A shareholder of Geron Corp. has filed a derivative suit against current and former members of the biopharmaceutical company's top ...
Read More 
Grabar Law Office In the News: AI Audio Co. Brass Accused of Acquisition Accounting Errors
By Grabar Law |
Executives and directors of California-based voice recognition technology company SoundHound Inc. were hit with a shareholder derivative suit alleging they ...
Read More 
Grabar Law Office In The News: Block’s Dorsey, Others Face Derivative Suit Over AML Woes
By Grabar Law |
Officers and directors of Square and Cash App parent company Block Inc. face a shareholder derivative complaint over alleged anti-money ...
Read More 
Grabar Law Office In The News: Micron CEO Accused Of Insider Trading In Fla. Investor Suit
By Grabar Law |
A Micron Technology Inc. shareholder has accused the company CEO and several board members of insider trading after selling $70 million worth ...
Read More 
GRABAR LAW OFFICE IN THE NEWS: Biotech Co.’s Facility Failures Lost Investors Money, Suit Says
By Grabar Law |
The executives and directors of biotechnology company Humacyte Inc. have been hit with a shareholder derivative suit in North Carolina ...
Read More 
GRABAR LAW OFFICE FILES ANTITRUST CLASS ACTION ON BEHALF OF MERCHANTS THAT ACCEPT VISA DEBIT CARDS
By Grabar Law |
Grabar Law Office has filed a significant class action lawsuit against Visa Inc., alleging that Visa has systematically abused its ...
Read More 
GRABAR LAW OFFICE FILES ANTITRUST CLASS ACTION ON BEHALF OF INDEPENDENT PHARMACIES AGAINST GOODRX AND MAJOR PBMS
By Grabar Law |
Grabar Law Office has filed a class action lawsuit on behalf of independent pharmacies, challenging the anticompetitive practices of GoodRx ...
Read More 
Grabar Law Office Files Motion to Intervene on Behalf of the State of Louisiana to Recover Settlement Funds
By Grabar Law |
As alleged in its motion and proposed accompanying complaint, Plaintiff, the State of Louisiana, brought its action with respect to ...
Read More 
Joshua H. Grabar’s Article, “Shareholder Litigation in The Age of Financial and Social Responsibility,” is Published by Engaging Local Government Leaders (ELGL)
By Grabar Law |
In securities class actions, plaintiffs bring a suit as a class seeking compensation from defendants for damages resulting from a ...
Read More 
Grabar Law Office Files Complaint Pursuant to 8 DEL. C. § 220 to Compel Inspection of Books and Records of Zuora, Inc.
By Grabar Law |
The Complaint follows a Section 220 Demand Letter (the “Demand”) served Defendant and Tien Tzuo (“Tzuo”), Zuora’s Chief Executive Officer ...
Read More 
Grabar Law Office Files Complaint Pursuant to 8 DEL. C. § 220 to Compel Inspection of Books and Records of CV Sciences, Inc.
By Grabar Law |
Plaintiff brings this action pursuant to 8 Del. C. § 220 (“Section 220”) to enforce Plaintiff’s statutory right to inspect ...
Read More 
Grabar Law Office Recognized as Top Commercial Litigation Firm
By Grabar Law |
Grabar Law Office is pleased to have been selected as "Best Commercial Litigation Firm - Pennsylvania" for 2020. "Grabar Law ...
Read More 
Blue Health Insurers Reach Tentative Antitrust Settlement For $2.7 Billion
By Grabar Law |
A tentative settlement has been negotiated with The Blue Cross Blue Shield insurance group to end a sweeping antitrust suit ...
Read More 
Google’s Parent Alphabet Inc. Pledges $310 Million To Expand Diversity Efforts and Resolve Shareholder Litigation
By Grabar Law |
Google's parent Alphabet Inc. pledged $310 million to expand diversity efforts and resolve shareholder litigation that alleged the company’s board ...
Read More 
GRABAR LAW OFFICE INVESTIGATES POTENTIAL SHAREHOLDER DERIVATIVE ACTION ON BEHALF OF SHAREHOLDERS OF CABOT OIL & GAS CORPORATION (NYSE: COG)
By Grabar Law |
The investigation focuses on whether the Company’s Board of Directors and/or officers breached their fiduciary duties. It is alleged that ...
Read More 
Interior Molded Door Manufacturers Agree to Settle class actions for $75 million.
By Grabar Law |
Defendant door makers Jeld-Wen and Masonite were accused of using their market dominance to fix the prices for indoor molded ...
Read More 
Grabar Law Office Files Class Action Complaint Against Manufacturers of the Pharmaceutical Drug Bystolic®
By Grabar Law |
The Class Action Complaint against AbbVie, Inc. (“AbbVie”); Allergan, Inc., Allergan Sales, LLC, and Allergan USA, Inc. (collectively, “Allergan”); and ...
Read More